المصدر: NASDAQ Stocks / 12 نوفمبر 2024 02:29:14 America/New_York
Fintel reports that on November 11, 2024, Piper Sandler downgraded their outlook for Xeris Biopharma Holdings (LSE:0A8E) from Overweight to Neutral.
https://www.nasdaq.com/articles/piper-sandler-downgrades-xeris-biopharma-holdings-lse-0a8e